baber/WOPTO huggingface dataset:
Patent AU-617416-B2 (AU)
Title: New 6-substituted mitomycin analogs
Inventor: REMERS WILLIAM A
IPC: A61K31/495
Filed: 1988-12-20
Granted: 1991-11-28
Abstract: Novel methods for treatment of neoplastic disease states in animals, which methods comprise administering a therapeutically effective amount of a compound of the formula V, <CHEM> wherein: Y is hydrogen or lower alkyl; and X is a radical of the formula -O-R, wherein R is: N,N-di(hydroxy lower alkyl)amino lower alkyl, or tri-lower alkoxy silyl lower alkyl, or cyclo lower alkyl, or halo substituted lower alkoxy lower alkyl, or tetrahydro pyranyl, or carboethoxy lower alkyl, or 1-lower alkyl pyrrolidinyl lower alkyl, or N-pyrrolidinyl lower alkyl, or 1-lower alkyl pyrrolydinyl, or dioxanyl, or hydroxy lower alkenyl, or hydroxy lower alkyl thio lower alkyl thio lower alkyl, or dioxanyl lower alkyl, or lower alkyl thio lower alkyl, or phenyl thio lower alkyl, or phenoxy lower alkyl, or thiophenyl lower alkyl, or 1-lower alkyl piperidyl, or alkyl carbonyl amino alkyl, or N-piperidyl lower alkyl, or lower alkoxy lower alkyl or lower alkyl thio hydroxy lower alkyl, or 1-lower alkyl N-piperazinyl lower alkyl, or N-thiomorpholinyl lower alkyl.
Patent AU-717244-B2 (AU)
Title: Method and apparatus of preserving power of a remote unit in a dispatch system
Inventor: LEKVEN ERIC J
IPC: H04B1/16
Filed: 1997-06-06
Granted: 2000-03-23
Abstract: To reduce the power consumption of a remote unit in a dispatch system the remote unit enters a dormant state. A base station transmits a forward link broadcast signal and monitors a common access channel. A first remote unit continually receives and decodes the forward link broadcast signal and determines whether said forward link broadcast signal comprises active signals. If the remote unit determines that the forward link broadcast signal comprises no active signals for some a duration T1, the first remote unit enters a dormant mode. In the dormant mode the remote unit sporadically receives and decodes said forward link broadcast signal. If this remote unit or any other remote unit on the same net presses a push to talk button, it transmits a message on the common access channel. In response, every remote unit on the net which is in a dormant state exits the dormant state and continually monitors the forward link broadcast signal.
Patent AU-706781-B2 (AU)
Title: Permanent heat activated transfer printing process and composition
Inventor: HALE NATHAN S
IPC: C09D11/00
Filed: 1995-09-01
Granted: 1999-06-24
Abstract: An image is printed on a medium by means of a computer-driven printer (6) using an ink composition comprising heat-activated dye solids, without activating the dye solids during the process of printing onto the medium. The image is transferred from the medium to the object (8) on which the image is to permanently appear by applying heat and pressure to the medium to activate the dye and transfer the image to the object (8). The liquid form of the ink composition uses a liquid carrier and an emulsifying enforcing agent which has an affinity for the dye. The emulsifying enforcing agent shields the heat-activated dye both prior to, and during, the printing process.
Patent AU-666358-B2 (AU)
Title: Venting closure
Inventor: GREGORY JAMES L
IPC: B65D51/16
Filed: 1993-04-19
Granted: 1996-02-08
Abstract: A plastic venting closure (20) comprising a base wall (21), a peripheral skirt (22) having internal threads (23) adapted to engage the threads (24) of a container and wherein the threads are interrupted at circumferentially spaced points to define axial venting passages (25) for dissipating pressure of the contents as the closure is unthreaded from a container. At least some of the passages have an integral rib (26) thereon spaced from the threads and extending axially. The radial thickness of each rib is less than that of the threads and preferably is arcuate in a radial direction and arcuate in a axial direction and preferably has an axial length greater than a transverse width such that it may span and engage several threads at the same time. The closure can be used with a glass container having a continuous thread and a plastic container having continuous thread or an interrupted thread. By having each rib (26) arcuate in an axial direction it may engage a plurality of threads (24) at different radial points on the rib thereby minimizing application and removal torque while centering the container relative to the closure. <IMAGE>
Patent AU-657613-B2 (AU)
Title: Process for the preparation of substituted indanones
Inventor: WEISSE LAURENT
IPC: C07C45/46
Filed: 1993-04-27
Granted: 1995-03-16
Abstract: 1-Indanones of the formula III or IIIa <IMAGE> in which R<1> to R<7> preferably denote hydrogen or alkyl or adjacent radicals R<1> to R<4> form a ring, are obtained in a one-step reaction by reacting a compound I <IMAGE>  with a compound of the formula II <IMAGE> in liquid hydrogen fluoride.
Patent AU-697569-B2 (AU)
Title: Vacuum skin package and composite film therefor
Inventor: MIRANDA NATHANIEL R
IPC: B65D75/26
Filed: 1995-11-14
Granted: 1998-10-08
Abstract: A composite film and vacuum skin package for packaging a product such as a fresh red meat is disclosed. The composite film is thermoformed and sealed under vacuum to a support member to completely enclose a product which is positioned on the support member. The composite film is a permeable film weakly bonded to an impermeable film, permitting the impermeable film to be peeled from the package while leaving the permeable film intact so that the fresh red meat product can bloom from a purplish color to a desirable red color upon exposure to oxygen. The permeable and impermeable films are fully peelable without the need for a migratable wax to enhance peelability. <IMAGE>
Patent AU-642129-B2 (AU)
Title: Reservoir for capsule for oral administration
Inventor: FABER MATHIJS
IPC: A61J1/00
Filed: 1989-07-28
Granted: 1993-10-14
Abstract: The invention relates to a reservoir for at least one capsule for oral administration which comprises a substance which is dangerous for the environment, in particular a radioactive composition, which reservoir can be enclosed within an at least substantially cylindrical shielding sleeve, has a closed bottom and can be closed at its open upper end by means of a cap, the reservoir internally comprising a plurality of longitudinal ribs. The reservoir is prefereably constructed so that it is locked against rotation within the shielding sleeve. The invention further relates to a shielded holder comprising the last-mentioned locked reservoir and a shielding sleeve having a bottom portion with an internal cross-section which is triangular to dodecagonal or forms a segment of a circle.
Patent AU-628075-B2 (AU)
Title: Novel peptidase inhibitors
Inventor: SCHIRLIN DANIEL
IPC: C07D233/64
Filed: 1989-09-01
Granted: 1992-09-10
Abstract: This invention relates to analogs of peptidase substrates in which the nitrogen atom of the scissile amide bond of a partial retropeptide analog of the substrate has been replaced by a difluoromethylene moiety. These peptidase substrate analogs provide specific enzyme inhibitors for a variety of proteases, the inhibition of which exert valuable pharmacological activities and therefore have useful physiological consequences in a variety of disease states.
Patent AU-633850-B2 (AU)
Title: Fluorosubstituted benzene derivatives
IPC: C07C311/13
Filed: 1989-10-09
Granted: 1993-02-11
Abstract: Fluorine-substituted benzene derivatives of the general formula I 
<IMAGE>
 in which Y represents an OH- or -NHSO2R<1> group with R<1> having the meaning of a 
<IMAGE>
group or a straight- or branched-chain alkylene group having from 1 to 10 carbon atoms which is optionally substituted by 1 to 6 fluorine atoms and carries a fluorine atom or the radical V at the end, in which V stands for hydrogen or the radicals U-OR<5> or 
<IMAGE>
 where U represents a CO or SO2 radical, R<5> represents hydrogen, a saturated, unsaturated, straight- or branched-chain or cyclic hydrocarbon radical having up to 16 carbon atoms and optionally substituted by 1 to 6 hydroxyl groups, R<6> and R<7> independently of one another represent hydrogen, a straight- or branched-chain alkyl group having 1 to 16 carbon atoms and optionally substituted by 1 to 6 hydroxyl groups or 1 to 12 fluorine atoms.
Patent AU-754293-B2 (AU)
Title: Acetic acid reactive distillation process based on DME/methanlol carbonylation
Inventor: VOSS BODIL
IPC: C07C53/08
Filed: 1999-08-05
Granted: 2002-11-14
Abstract: A process for the production and purification of acetic acid by carbonylation of methanol, DME or reactive derivatives thereof in a distillation column containing a homogenous catalyst system.
Patent AU-719674-B2 (AU)
Title: High molecular weight trichoderma cellulase
Inventor: BOWER BENJAMIN S
IPC: A23L7/104
Filed: 1997-10-07
Granted: 2000-05-18
Abstract: A purified novel cellulase composition is provided which may be isolated from a fermentation culture of Trichoderma longibrachiatum and has a molecular weight of about 95-105 kD as approximated on SDS-PAGE (see FIG. 1), a pl of about 5.6-6.8 as estimated on an IEF gel and a pH optimum of about 5.0 on RBB-CMC when measured at 65 DEG  C. and pH 4 or lower at temperatures of 40 DEG  C. and 50 DEG  C.
Patent AU-582621-B2 (AU)
Title: Imidazole derivatives, their preparation and their use as fungicides
Inventor: PETTMAN ROGER BRUCE
IPC: C07D403/06
Filed: 1986-01-20
Granted: 1989-04-06
Abstract: The invention provides imidazole-5-carboximidate of general formula   <CHEM> wherein R represents an optionally substituted phenyl group, R<1> represents an optionally substituted alkyl, cycloalkyl, alkenyl, aryl or aralkyl group, R<2> represents an optionally substituted alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, aryl or aralkyl group, and X represents an oxygen or sulphur atom or a group -NR<3>-, where R<3> represents a hydrogen atom or an alkyl group or R<2> and R<3> together with the interjacent nitrogen atom represent a 5- or 6-membered saturated or unsaturated heterocyclic ring optionally containing one or two further heteroatoms; processes for their preparation and their use as fungicides.
Patent AU-623769-B2 (AU)
Title: Proteinase inhibitors, process for the preparation thereof and medicaments containing these
Inventor: FRITZ HANS
IPC: A61P15/00
Filed: 1990-05-11
Granted: 1992-05-21
Abstract: The invention comprises peptide variants based on the domains with inhibitory activity of human bicunin (i.e. the component with inhibitory activity of inter- alpha -trypsin inhibitor, or the acid-stable serum trypsin inhibitor, or the urinary trypsin inhibitor), methods for the preparation of these peptide variants with the aid of genetic engineering methods with microorganisms (bacteria, lower eukaryotes), and pharmaceutical compositions containing these peptide variants. The peptide variants are characterised by their ability to inhibit serine proteases, e.g. pancreatic and granulocytic elastase, cathepsin G or plasma kallikrein.
Patent AU-586239-B2 (AU)
Title: Stabilizers with arylphosphinic structure for perfluoropolyether oils and greases
Inventor: GAVEZOTTI PIERO
IPC: C10N30/10
Filed: 1986-04-17
Granted: 1989-07-06
Abstract: New products having the structure of arylphosphines or of derivatives of arylphosphines with an oxygen or sulphur atom directly bonded to the phosphorus atom, containing perfluoroalkylether chains, characterized in that such chains are bonded to the benzene ring through a non-perfluorinated bridge, and are obtained by a process substantially decreasing their production costs, and suitable to be used as stabilizers of perfluoropolyether oils and greases to prevent their degradation in the presence of metals, and the corrosion of the same metals, such as, e.g., Al, Ti, V, or their alloys, when operating in oxidizing and high-temperature environments.
Patent AU-588606-B2 (AU)
Title: Binders for aqueous, physically drying anticorrosion coatings based on a polymer dispersion containing a monoalkyl phosphate
Inventor: DERSCH ROLF
IPC: C08L25/14
Filed: 1986-06-27
Granted: 1989-09-21
Abstract: Aqueous anticorrosion coatings which contain a binder based on styrene/alkyl (meth)acrylate copolymer dispersions which contain (a) from 0.5 to 4% by weight of a monoalkyl phosphate having a phosphorus content of not less than 7% and (b) from 0.1 to 3.5% by weight of an oxyethylated alkylphenol, where alkyl is of 8 or 9 carbon atoms, and/or of an oxyethylated C8-C18-fatty alcohol, the percentages by weight being based on the amount of copolymer and the copolymers having a mean particle diameter of from 0.01 to 0.5  mu m and an MFT of from 5 DEG  to 50 DEG  C., exhibit good adhesion, especially to iron and steel, and are particularly resistant to weathering.
Patent AU-545416-B2 (AU)
Title: A process for enzymatic production of peptides
Inventor: JOHANSEN J T WIDMER F
IPC: C12P21/04
Filed: 1980-04-01
Granted: 1985-07-11
Abstract: A process for producing a peptide comprises reacting a substrate selected from amino acid esters, peptide esters, depsipeptides, optionally N-substituted amino acid amides and peptide amides, and optionally N-terminal protected peptides, with an amine component selected from amino acids, optionally N-substituted aminoacid amides and amino acid esters in the presence of a carboxypeptidase enzyme in an aqueous solution or dispersion having a pH from 5 to 10.5.
Patent AU-606578-B2 (AU)
Title: Chromatographic recovery of erythropoietin
Inventor: POR-HSIUNG LAI
IPC: C07K1/14
Filed: 1986-06-20
Granted: 1991-02-14
Abstract: Chromatographic procedures are individually and jointly applied to the rapid and efficient isolation of biologically active proteins and especially glycoproteins such as recombinant erythropoietin present in the medium of growth of genetically transformed mammalian host cells. Illustratively, recombinant EPO is isolated from culture fluids by reverse phase chromatography employing a C4 or C6 column and elution with ethanol. Recombinant erythropoientin may also be purified by anion exchange chromatography employing, e.g., a DEAE resin, with preliminary selective elution of contaminant materials having a lower pKa than erythropoietin from the resin under conditions mitigating against acid activated protease degradation. Practiced serially, the two chromatographic procedures allow for high yields of biologically active recombinant erythropoietin from mammalian cell culture media.
Patent AU-521507-B2 (AU)
Title: Cofactor indicator system
Inventor: CAMERON ERMA C
IPC: G01N33/52
Filed: 1980-10-09
Granted: 1982-04-08
Abstract: A composition, test device, method of making a test device and process for determination of an analyte in a liquid sample are disclosed. More particularly, there is provided a composition for the determination of an analyte in a sample which composition comprises an analyte-responsive component comprising a pyridine nucleotide susceptible of reduction in response to the presence of the analyte, an uncoupler effective to generate an oxidizing substance from the reduced form of said pyridine nucleotide, a peroxidatively active substance, and an indicator which, when oxidized, is not susceptible to reduction by said reduced pyridine nucleotide. The pyridine nucleotide is either nicotine adenine dinucieotide (NAD) or nicotine adenine dinucleotide phosphate (NADP).
Patent AU-690471-B2 (AU)
Title: Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls
Inventor: LEONARDI AMEDEO
IPC: A61K31/4439
Filed: 1996-06-28
Granted: 1998-04-23
Abstract: 1,4-Dihydropyridines have been found to counter several processes which play a role in the development of atherosclerotic vascular lesions, such as myocytes proliferation and migration, cholesterol metabolism in macrophages and oxidative modification of low density lipoproteins. They are therefore useful in the manufacture of medicaments for preventing, arresting and reversing atherosclerotic degradation in the arterial walls of humans. The preferred 1,4-dihydropyridines for this purpose are lercanidipine, (S)-lercanidipine and (R)-lercanidipine.
Patent AU-535301-B2 (AU)
Title: Zinc peroxide oxidant in explosives
Inventor: HAGEL RAINER
IPC: C06B33/00
Filed: 1980-12-10
Granted: 1984-03-15
Abstract: A process for promoting the oxidation of an explosive-containing mixture or a pyrotechnical mixture involves utilizing zinc peroxide as the sole or predominant oxidant in the mixture. Preferably the zinc peroxide has an available oxygen content of more than 12.3% by weight.
Patent AU-680494-B2 (AU)
Title: Manufacturing matrices
Inventor: BJORK SETH
IPC: A61K9/20
Filed: 1994-04-14
Granted: 1997-07-31
Abstract: PCT No. PCT/SE94/00331 Sec. 371 Date Oct. 11, 1995 Sec. 102(e) Date Oct. 11, 1995 PCT Filed Apr. 14, 1994 PCT Pub. No. WO94/23703 PCT Pub. Date Oct. 27, 1994Porous cellulose matrices with a defined particle size and a significantly higher porosity (i.e. pore volume) than conventional formulations, such as pellet formulations containing cellulose and binders are prepared. The cellulose is mechanically treated with low adhesion to the process equipment during a controlled gradual addition of an aqueous based fluid, optionally containing a surface-active ingredient, into regular particles, which are finally dried to obtain dry porous cellulose matrices. The so obtained matrices can be used as carriers for bioactive substances in multiple-unit preparations or tablets.
Patent AU-775915-B2 (AU)
Title: Improved structural panel and method of manufacture
Inventor: CLIFFORD DAVID D ARCY
IPC: B32B15/08
Filed: 2000-08-10
Granted: 2004-08-19
Abstract: A fibrous core material is disposed between and bonded to metal skins to form a structural laminate having comparable strength to steel sheets of greater weight.
Patent AU-714498-B2 (AU)
Title: Analytical element and method for the determination of a specific binding ligand using a vanadium bromoperoxidase as a signal-generating enzyme
Inventor: FRIEDMAN ALAN ERIC
IPC: C12Q1/28
Filed: 1996-08-16
Granted: 2000-01-06
Abstract: An analytical element can be used to sensitively and rapidly detect a wide variety of specific binding ligands in either a competitive or sandwich assay format. The assays are carried out using a vanadium bromoperoxidase-labeled immunoreactant and a chemiluminescent signal-providing wash composition which comprises a 2,3-dihydro-1,4-phthalazinedione derivative; a halogen, pseudohalogen, halogen-providing source or pseudohalogen-providing source; and a peroxide or a peroxide-generating reagent composition.
Patent AU-708805-B2 (AU)
Title: Surgical cassette adapter
Inventor: FANNEY DOUGLAS M
IPC: A61M5/14
Filed: 1996-10-16
Granted: 1999-08-12
Abstract: A surgical cassette adapter (10), comprising : a housing adapted to receive a surgical cassette (18); a means (28,30) contained within the housing for controlling irrigation and aspiration fluid flows within the cassette (18); and a communications port (34,36) connected to the means for controlling irrigation and aspiration fluid flows within the cassette (18). A surgical system comprising : a surgical console (12); a surgical cassette (18); and an adapter (10) that receives the surgical cassette (18) wherein the adapter (10) communicates with the surgical console (12) is also described. <IMAGE>
Patent AU-610504-B2 (AU)
Title: A one-component tissue adhesive and a process for the production thereof
Inventor: HEIMBURGER NORBERT
IPC: A61K38/48
Filed: 1987-07-03
Granted: 1991-05-23
Abstract: 1. Claims for the Contracting States : AT, BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A tissue adhesive containing, in liquid or solid form, fibrinogen, F XIII, a thrombin inhibitor, prothrombin factors and calcium ions and, where appropriate, a plasmin inhibitor. 1. Claims for the Contracting States : GR, ES A process for the production of a tissue adhesive, which comprises addition to an aqueous isotonic solution which has a pH of 7.5, which has been, where appropriate, pasteurized and, where appropriate, sterilized by filtration, and which contains at least 16 g/l human fibrinogen, 2 g-atoms of calcium per mol of fibrinogen and 1-6 g/l L-arginine monohydrochloride, of sufficient of a solution, which has, where appropriate, been pasteurized, of human factor XIII, of human albumin, of prothrombin concentrate, of antithrombin III and of aprotinin and, where appropriate, Na glutamate and isoleucine that the freeze-dried solution contains, in 1/4 of the volume dispensed into the container, these substances in the following concentration ranges : 65-115 mg/ml of human fibrinogen, 40-80 U/ml of factor XIII 4-40 mg/ml of human albumin, 1-50 IU/ml of PPSB (prothrombin factors), based on F II (prothrombin) 0.01-50 IU/ml of antithrombin III and, where appropriate, 1-10, 000 KIU of aprotinin/ml and 0-20 g/l of Na glutamate and 0-20 g/l of isoleucine.
Patent AU-637502-B2 (AU)
Title: Agents for treating addiction to habit-forming drugs
IPC: C07D495/04
Filed: 1991-06-11
Granted: 1993-05-27
Abstract: Agents for treating addiction to habit-forming drugs and symptoms related to withdrawal of said drugs which agents are 4-[bis(halophenyl)methylene]-1-piperidinyl derivatives of formula <CHEM> or a pharmaceutically acceptable acid addition salt thereof, wherein A represents -CH=CH- or -S-.
Patent AU-644003-B2 (AU)
Title: Process for producing a poly-1-olefin
Inventor: BOHM LUDWIG
IPC: C08F4/646
Filed: 1991-05-24
Granted: 1993-12-02
Abstract: Poly-1-olefins, in particular polyethylene, are produced using a Ziegler catalyst whose transition metal constituents are produced by reacting a transition metal compound of titanium, zirconium, vanadium or chromium with a gel-like dispersion of a magnesium, alcoholate. An organoaluminium compound is used as co-catalyst. The polymerizates are obtained in high to very high yields and the particle size distribution of the polymerizates can be controlled.
Patent AU-597744-B2 (AU)
Title: Method and device for measuring the distance between the discs of a refiner
Inventor: KAERNAE JUHANI
IPC: B02C/
Filed: 1987-09-30
Granted: 1990-06-07
Abstract: PCT No. PCT/FI87/00132 Sec. 371 Date Jun. 14, 1988 Sec. 102(e) Date Jun. 14, 1988 PCT Filed Sep. 30, 1987 PCT Pub. No. WO88/03054 PCT Pub. Date May 5, 1988.This invention is related to a method and device for measuring the distance ( delta ) between the discs of a refiner, in which method a magnetic field is generated by means of a coil (5) placed at one disc (4), which magnetic field is allowed to run at least partly through the other disc (3). According to the invention the measuring is carried out by using the actual distance between the refiner discs as the object of measuring in that the magnetic flux over the distance between the discs caused by the coil (5), which is formed at least at one refiner-disc tooth (7) or comparable element, is measured such that the flux running over the distance between two opposite teeth (7,8) is detected by means of another coil (6), such as is formed round at least either of said teeth, the signal induced in the coil being interpreted as a quantity that expresses the distance ( delta ) between the teeth.
Patent AU-746540-B2 (AU)
Title: Discharge valve for flushing cisterns
Inventor: KORTE HERMANN
IPC: E03D1/14
Filed: 1998-11-02
Granted: 2002-05-02
Abstract: The outlet valve for a cistern has the lifting mechanism (4) at the overflow pipe (3) area. The base valve (2) is held open during flushing by a retainer (5) controlled by a float. For a full flushing action, the first float (50) alone controls the retainer. For partial flushing, a second float (60) is activated over the first float so that, at the end of the partial flushing, it acts on the first float (50) to release the retainer which holds the base valve open.